Vaxart, Inc. logo

Vaxart, Inc.

NASDAQ:VXRT

Overview | Financials
Company Name Vaxart, Inc.
Symbol VXRT
Currency USD
Price 0.396
Market Cap 90,262,197
Dividend Yield 0%
52-week-range 0.28 - 1.07
Industry Biotechnology
Sector Healthcare
CEO Mr. Cezar Andrei Floroiu M.B.A.
Website https://vaxart.com

An error occurred while fetching data.

About Vaxart, Inc.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the

Related Stocks

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.75 USD

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

42.26 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.339 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

60.36 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

1.02 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

78.09 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

6.95 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.81 USD

Financials

Numbers are in millions USD

Numbers are in millions USD